Bruce Jackson
Stock Analyst at Benchmark
(1.08)
# 3,865
Out of 5,147 analysts
124
Total ratings
30.09%
Success rate
-18.79%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CV CapsoVision | Maintains: Speculative Buy | $5 → $14 | $5.49 | +155.01% | 2 | Dec 31, 2025 | |
| ABT Abbott Laboratories | Initiates: Buy | $145 | $116.35 | +24.62% | 1 | Oct 10, 2025 | |
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.91 | +201.67% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $1.12 | +1,155.61% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.61 | +388.84% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $5.23 | +531.58% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $2.98 | +671.81% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $190.30 | -57.96% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $9.83 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $103.38 | -37.13% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $0.21 | - | 3 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $6.93 | +332.90% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.26 | +372.41% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.01 | +197.03% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $1.08 | +362.96% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $300 | $11.40 | +2,531.58% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $6.55 | +816.03% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.21 | +7,818.03% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $0.87 | +2,652.29% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.25 | +1,923.47% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.04 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $19.90 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $2.79 | +28,615.00% | 1 | Aug 8, 2022 |
CapsoVision
Dec 31, 2025
Maintains: Speculative Buy
Price Target: $5 → $14
Current: $5.49
Upside: +155.01%
Abbott Laboratories
Oct 10, 2025
Initiates: Buy
Price Target: $145
Current: $116.35
Upside: +24.62%
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.91
Upside: +201.67%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $1.12
Upside: +1,155.61%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.61
Upside: +388.84%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $5.23
Upside: +531.58%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $2.98
Upside: +671.81%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $190.30
Upside: -57.96%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.83
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $103.38
Upside: -37.13%
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.21
Upside: -
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $6.93
Upside: +332.90%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.26
Upside: +372.41%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.01
Upside: +197.03%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.08
Upside: +362.96%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $300
Current: $11.40
Upside: +2,531.58%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $6.55
Upside: +816.03%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.21
Upside: +7,818.03%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $0.87
Upside: +2,652.29%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.25
Upside: +1,923.47%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.04
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $19.90
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $2.79
Upside: +28,615.00%